CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer
CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer have?
CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer has 51 citations in the OpenAlex counts ScholarIQ stores.
When was CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer published?
CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer has 2017 year in the ScholarIQ index.
What is the open-access status of CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer?
CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer has diamond oa status in the ScholarIQ index.
What is the DOI of CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer?
The DOI for CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer is on the source record.
What is the PMID of CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer?
The PMID for CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer is on the source record.
What is the OpenAlex record for CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer?
The OpenAlex for CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer is on the source record.